Brigham and Women's Hospital
Aurora, Colorado
Marc Bonaca, MD, MPH, is a cardiologist and vascular medicine specialist serving as Executive Director of CPC Clinical Research and Director of Vascular Research & Professor of Medicine at the University of Colorado Anschutz.
Dr. Bonaca earned his medical degree from the University of Connecticut School of Medicine and his MPH at Harvard University. He served as a Cardiovascular Research Fellow with the TIMI Study Group with the Cardiovascular Division of Brigham and Women’s Hospital.
After completion of his training he joined the faculty Brigham and Women’s Hospital and Harvard Medical School and became an Investigator at the TIMI Study Group. In 2018, he joined the faculty at the University of Colorado as Professor of Medicine and the William R. Hiatt Endowed Chair in Cardiovascular Research. At CPC, he has led several clinical trials including VOYAGER-PAD, PREVENT-HD, ASPEN, and BRIGHT, and is leading several ongoing trials, including EVOLVE-MI and MOONRAKER program that includes REDEFINE-HF, CONFIRMATION-HF and FINALITY-HF.
Dr. Bonaca’s research focus is on ischemic risk in patients with atherosclerotic vascular disease, risk prediction, and risk modification through the use of pharmacologic and biologic therapies. He has experience in the design and conduct of large multicenter randomized clinical trials as well as analyses in registries and real-world datasets. His areas of interest include PAD, PVD, and diabetes, with a focus on the breadth of risk including ischemic limb outcomes, microvascular complications, and major adverse cardiovascular events. He is also investigating the cardiac, vascular, and thrombotic complications associated with novel oncologic therapies.
Wednesday, June 4, 2025
1:38 PM – 1:48 PM CT